Related Experiment Video
Updated: Mar 15, 2026

03:05
Author Spotlight: Advancing Early Detection and Treatment of Gastrointestinal Tumors
Published on: February 16, 2024
1.6K
Risk Factors for Lateral Margin Positivity Following Endoscopic Submucosal Dissection in Patients with Early Gastric
Min-Kyung Yeo1, Sun Hyung Kang2, Hyuk Soo Eun2
1Department of Pathology, Chungnam National University College of Medicine, Daejeon 35015, Republic of Korea.
Cancers
|March 14, 2026
Summary
Subepithelial (SE) spread in early gastric cancer (EGC) may lead to positive lateral margins (LM+) after endoscopic submucosal dissection (ESD). SE spread exceeding 5 mm significantly increases LM+ risk, suggesting wider margins for certain EGC lesions.
Area of Science:
- Gastroenterology
- Surgical Oncology
- Pathology
Background:
- Positive lateral margins (LM+) after endoscopic submucosal dissection (ESD) for early gastric cancer (EGC) can result in residual disease.
- Subepithelial (SE) spread beneath normal mucosa is a potential, yet unconfirmed, cause of LM+.
Purpose of the Study:
- To investigate the association between subepithelial (SE) spread and lateral margin positivity (LM+) in early gastric cancer (EGC) after endoscopic submucosal dissection (ESD).
- To identify predictors of LM+ in EGC patients undergoing ESD.
Main Methods:
- Retrospective review of 248 EGC patients who underwent ESD (21 LM+ cases, 227 LM- controls).
- Comparison of clinicopathologic and endoscopic factors.
- Multivariate logistic regression analysis to identify LM+ predictors.
- Pathological evaluation of SE spread extent.
Main Results:
- Lesion size ≥ 2 cm was the sole independent predictor of LM+.
- SE spread length was significantly greater in LM+ cases (5.80 mm) compared to controls (2.60 mm).
- SE spread ≥ 5 mm markedly increased LM+ risk (OR 15.077).
Conclusions:
- Subepithelial (SE) spread, especially ≥ 5 mm, may obscure tumor boundaries, contributing to lateral margin positivity (LM+) in EGC.
- Consideration of wider marking and resection margins is advised for EGC lesions with features suggesting SE spread.
Related Concept Videos
Barrett Esophagus-I: Introduction
1.1K
Barrett's esophagus is a medical condition where the esophageal mucosa is significantly damaged by stomach acid or other digestive fluids, often due to long-term exposure associated with gastroesophageal reflux disease (GERD). In GERD, a weakened or abnormally relaxed lower esophageal sphincter allows stomach acid to flow persistently into the esophagus.
This constant acid exposure transforms the esophagus's pink mucosal lining (stratified squamous epithelium) into a type of lining more...
This constant acid exposure transforms the esophagus's pink mucosal lining (stratified squamous epithelium) into a type of lining more...
1.1K
Barrett Esophagus-II: Clinical Manifestations and Management
1.4K
Individuals with Barrett's esophagus are often asymptomatic, but they may experience symptoms commonly associated with GERD, such as heartburn and acid regurgitation. Additional symptoms can include difficulty swallowing, chest pain, unintentional weight loss, blood in the stool (which may appear black, tarry, or bloody), and episodes of vomiting.
To diagnose Barrett's esophagus, healthcare providers often recommend an endoscopy for those showing symptoms of acid reflux. The procedure...
To diagnose Barrett's esophagus, healthcare providers often recommend an endoscopy for those showing symptoms of acid reflux. The procedure...
1.4K

